Medical device maker Cur adds disclaimers to crowfunding site after questions about FDA rules

Earlier today, The Verge published a report about Cur, a company that launched a $50,000 crowdfunding campaign yesterday for a medical product — also called "Cur" — that has yet to gain FDA clearance. The story outlined the risks that Cur was running by going against FDA regulations that prohibit advertising and selling a product directly to consumers prior to obtaining FDA clearance. The story also outlined the difficulties that officials may face when trying to regulate campaigns that provide a "reward" in return for a "donation" from "investors" — instead of selling a product to consumers.

Continue reading…

Medical device maker Cur adds disclaimers to crowfunding site after questions about FDA rules